This is an example of an ADPP dataset and is based on input from the SDTM PP dataset. Other administrative data about the subjects are based on the ADSL dataset provided in Section x.x,Analysis Data Subject Level (ADSL).
Example
In this PK study, Cmax, time to reachCmax(tmax), and the baseline-corrected area under the plasma concentration–time curves (i) from start of product use (t0) to the last quantifiable nicotine concentration time point (AUC0-last) and (ii) fromt0to 10 minutes aftert0(AUC0-10’). The pharmacokinetic parameters were derived from plasma nicotine concentrations-versus-time data by means of noncompartmental analysis and corrected for baseline where the baseline (C0) was defined as the average concentration of the 3 time points prior tot0(45, 30, and 15 minutes prior tot0). The analysis methods for the baseline corrected values were provided in the study protocol.
This example shows the PP parameters calculated from time-concentration profiles for the nicotine for one subject at day 1. Typically, the same PP parameters would be provided for cotinine and NNN but are only shown for TMAX. Note that PPRFTDTC is populated in order to link the PP records to the respective PC records.
Other parameters may be calculated but are not shown. They may include: (1) R2, R Squared; (2) R2ADJ, R Squared Adjusted; (3) AUCIFO, AUC Infinity Obs; (4) AUCPEO, AUC %Extrapolation Obs; (5) AUCTAU, AUC Over Dosing Interval; (6) LAMZNPT, Number of Points for Lambda z; (7) LAMZUL, Lambda z Upper Limit; or (8) LAMZLL, Lambda z Lower Limit. These PP parameters are included in the controlled terminology.
Show parameters AUC for day 1. Note AUCALL was calculated as AUC from 0- to the last value and AUCINT was calculated as 0 to10 minutes. This interval is represented in PPSTINI, and PPENINT.
Rows 5-6:
Show parameter TMAX for cotinine and NNN.
pp.xpt
pp.xpt
Row
STUDYID
DOMAIN
USUBJID
PPSEQ
PPGRPID
PPTESTCD
PPTEST
PPCAT
PPORRES
PPORRESU
PPSTRESC
PPSTRESN
PPSTRESU
PPSPEC
PPANMETH
VISITNUM
VISIT
PPDTC
PPRFTDTC
PPSTINT
PPENINT
1
A123
PP
A2008
1
DAY1
TMAX
Time of CMAX
NICOTINE
5
m
5
5
m
PLASMA
non-compartmental analysis. and corrected for baseline
1
DAY 1
2022-01-07
2021-02-08T08:00
2
A123
PP
A2008
2
DAY1
CMAX
Max Conc
NICOTINE
13
ng/mL
13
13
ng/mL
PLASMA
non-compartmental analysis. and corrected for baseline
1
DAY 1
2022-01-07
2021-02-08T08:00
3
A123
PP
A2008
3
DAY1
AUCALL
AUC All
NICOTINE
11.4
h*ng/mL
11.4
11.4
h*ng/mL
PLASMA
non-compartmental analysis. and corrected for baseline
1
DAY 1
2022-01-07
2021-02-08T08:00
4
A123
PP
A2008
4
DAY1
AUCINT
AUC from T1 to T2
NICOTINE
6.0
h*ng/mL
6.0
6.0
h*ng/mL
PLASMA
non-compartmental analysis. and corrected for baseline
1
DAY 1
2022-01-07
2021-02-08T08:00
0
10
5
A123
PP
A2008
5
DAY1
TMAX
Time of CMAX
COTININE
6
m
6
6
m
PLASMA
non-compartmental analysis. and corrected for baseline
1
DAY 1
2022-01-07
2021-02-08T08:00
6
A123
PP
A2008
6
DAY1
TMAX
Time of CMAX
NNN
7
m
7
7
m
PLASMA
non-compartmental analysis. and corrected for baseline